FIELD: organic chemistry, chemical technology.
SUBSTANCE: invention relates to a method for preparing pure cis-isomer from mixture of cis-trans-isomers of the formula (I): wherein Ar represents phenyl or naphthyl optionally mono- or disubstituted with (C1-C5)-alkyl, (C1-C5)-alkoxy-group, halogen atom, trifluoromethyl, ester or amido-group; R represents (C1-C5)-alkyl wherein indicated formula (I) comprises chiral C1-carbon atom and adjacent chiral C2-carbon atom, and wherein C2-atom is added to hydrogen atom and to strong electron-acceptor group G chosen from group including nitro-, nitroso-group, nitrile, cyanato-, isocyanato-group, nitro-substituted aryl, sulfonyl and carbonyl, and wherein at least one atom or group added to C1-atom distinct from atoms or groups added to C2-atom that can be used as intermediate compound in synthesis of cis-isomers of benzamide-piperidine compounds eliciting activity as antagonists of NK-1 receptors. Method involves steps for dispersing a mixture of cis- and trans-isomers of the formula (I) in inert solvent medium wherein indicated cis-isomer is essentially less soluble as compared with indicated trans-isomer followed by heating indicated dispersion to complete dissolving indicated trans-isomer and dissolving at least 10 wt.-% of cis-isomer, maintaining indicated heating step for providing possibility for mutual conversion of indicated cis- and trans-isomers, cooling the indicated mixture providing crystallization of cis-isomer and separation of indicated crystalline cis-isomer from indicated solvent.
EFFECT: improved method of conversion.
9 cl, 1 tbl, 4 sch, 1 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIASTEREOSELECTIVE SYNTHESIS OF OPTICALLY ACTIVE CIS-NUCLEOSIDES, NUCLEOSIDE ANALOGS OR DERIVATIVES AND INTERMEDIATE COMPOUNDS FOR THIS METHOD | 1992 |
|
RU2105009C1 |
O-ACYL-4-PHENYLCYCLOALKANOLS, CIS/TRANSISOMERS THEREOF, SALTS THEREOF, AND PHARMACEUTICAL AGENT | 1994 |
|
RU2130921C1 |
BETA-LACTAMASE INHIBITORS | 2013 |
|
RU2654692C2 |
AMINES FOR PREPARING MEDICINAL AGENTS DESIGNATED FOR PROPHYLAXIS OF TUMOR CELLS PROLIFERATION | 1997 |
|
RU2176502C2 |
METHOD OF PRODUCING DIARYL CYCLOALKYL DERIVATIVES | 2005 |
|
RU2414459C2 |
SUBSTITUTED BENZYLAMINOPIPERIDINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF TREATMENT AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1996 |
|
RU2152930C2 |
DERIVATIVES OF N-ACYL-2-ARYLCYCLOALKYLAMINE STIMULATING MELATONIN SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF MELATONIN-STIMULATING BINDING | 1996 |
|
RU2162076C2 |
METHOD OF PRODUCING HETEROARYL PYRIMIDONE DERIVATIVE AND INTERMEDIATE COMPOUND OF HETEROARYL PYRIMIDONE DERIVATIVE | 2018 |
|
RU2741788C1 |
AMINOCYCLOHEXANOL ETHERS, COMPOSITION HAVING ANTIARRHYTHMIC ACTIVITY AND USES THEREOF | 1999 |
|
RU2252933C2 |
NOVEL METHOD FOR ISOMERISATION OF CONDENSED BICYCLIC STRUCTURES AND OBTAINING VITAMIN D ANALOGUES CONTAINING SAID STRUCTURES | 2011 |
|
RU2560184C2 |
Authors
Dates
2007-04-27—Published
2003-11-03—Filed